Investor Diligence and Decision Support
We support VC/CVC teams, Private Equity, Hedge Funds, and other investors with decision-grade intelligence in BioPharma, HealthTech, and AI-enabled healthcare. From fast diligence to ongoing monitoring, we help you validate assumptions, surface risks early, and act with confidence.
From identifying emerging trends and hidden risks to supporting diligence and portfolio decisions, we deliver concise, actionable recommendations that create an edge.
Our work commonly includes:
- Landscape + diligence (science, commercial, competitive dynamics)
- Company/asset profile (TAM, segmentation, growth drivers, value proposition)
- Opportunity/risk assessment (red flags, catalysts, scenarios, mitigations)
- Custom research aligned to your thesis and timelines (deal-specific questions, thesis validation, monitoring)
Typical engagement modes:
- Diligence Sprint (5–10 business days)
- Monthly monitoring and brief updates
- Decision workshops and AI-powered wargaming when stakes are high
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, linked to trending news.
Want to move faster on your next decision? Contact: info@lqventures.com
October 13, 2025
Lucid Diligence Brief: Shuttle Pharma x Molecule.ai LOI
October 11, 2025
Lucid Diligence Brief: Ascenta Capital Fund I, $325M final close
October 10, 2025
Latest Public Health News – Sept 27th to Oct 10th
October 10, 2025
Public Health Weekly News – October 10th 2025
October 9, 2025
Cell and Gene Therapy Weekly News – October 9th 2025
October 9, 2025
Latest Cardiovascular News – Sept 26th to Oct 9th 2025
October 9, 2025
Cardiovascular Weekly News – October 9th 2025
October 9, 2025
Latest Rare Disease News – Sept 26th to Oct 9th 2025
October 9, 2025
Vaccines Weekly News – October 9th 2025
October 9, 2025